Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy

Cell Death Dis. 2017 May 11;8(5):e2784. doi: 10.1038/cddis.2017.201.

Authors

Aline Hunger¹, Ruan Fv Medrano¹, Bryan E Strauss¹

Affiliation

¹ Viral Vector Laboratory, Center for Translational Investigation in Oncology, Cancer Institute of Sao Paulo/LIM 24, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.

No abstract available

Publication types

News
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Cell Death
Cyclin-Dependent Kinase Inhibitor p16
Genetic Therapy / methods*
Humans
Immunotherapy / methods*
Interferon-beta / genetics*
Mice

Substances

Cdkn2a protein, mouse
Cyclin-Dependent Kinase Inhibitor p16
Interferon-beta